936.2000 -14.15 (-1.49%)
NSE Aug 08, 2025 15:31 PM
Volume: 32,246
 

936.20
-1.49%
BOB Capital Markets Ltd.
Q2FY25 results were below our estimates on all fronts; however, ALPM expects H2 to be better than H1FY25 driven by healthy product mix
Alembic Pharmaceuticals Ltd. is trading below all available SMAs
More from Alembic Pharmaceuticals Ltd.
Recommended